Coasting acts through downregulation of VEGF gene expression and protein secretion

Human Reproduction

Volumn 19, Issue 7, 2004, Pages 1530-1538

  Garcia Velasco J A ^a,b   Zuniga A ^a   Pacheco, A ^a   Gomez R ^b   Simon C ^b   Remohi J ^b   Pellicer, A ^b  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b IVI RMA   (Spain)

Author keywords

Coasting; Ovarian hyperstimulation syndrome; VEGF

Indexed keywords

CD45 ANTIGEN; CHORIONIC GONADOTROPIN; ESTRADIOL; FLUORESCEIN ISOTHIOCYANATE; GONADORELIN ANTAGONIST; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE; PROTEIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRANULOSA CELL; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OOCYTE TRANSPORT; OVARY DISEASE; OVARY FOLLICLE CELL; OVARY FOLLICLE FLUID; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; TREATMENT OUTCOME;

EID: 3242888897     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh298     Document Type: Article

References (31)

1. Agrawal R, Jacobs H, Payne N and Conway G (2002) Concentration of vascular endothelial growth factor released by cultured luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78,1164-1169.
2. Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C, Lower A and Grudzinskas J (2001) Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified coasting strategy based on ultrasound for identification of high-risk patients. Hum Reprod 16,24-30.
3. Benadiva C, Davis O, Kligman I, Moomjy M, Liu H and Rosenwaks Z (1997) Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67,724-727.
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162,156-159.
5. Christenson L and Stouffer R (1997) Follicle-stimulating hormone and luteinizing hormone/chrorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 82,2135-2134.
6. Chun S, Eisenhauer K, Minami S, Billig H, Perlas E and Hsueh A (1996) Hormonal regulation of apoptosis in early astral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology 137,1447-1456.
7. Delvigne A and Rozenberg S (2001) Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod 16,2491-2495.
8. Delvigne A and Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8,559-577.
9. Enskog A, Henriksson M, Unander M, Nilsson L and Brannstrom M (1999) Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 71,808-814.
10. Fauser BC and Van Heusden AM (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18,71-106.
11. Filicori M, Cognini GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D and Ciampaglia W (2002) Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87,1156-1161.
12. Fluker MR, Hooper WM and Yuzpe AA (1999) Withholding gonadotrophin ('coasting') to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Ferfil Steril 71,294-301.
13. Gagné D Pagé M, Robitaille G, Hugo P and Gosselin D (2004) Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 19,221.
14. Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohi J, Simon C and Pellicer A (2001) Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 16,2533-2539.
15. Gargett C, Zaitseva M, Bucak K, Chu S, Fuller P and Rogers P (2002) 17β-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-α and -β. J Clin Endocrinol Metab 87,4341-4349.
16. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z and Caspi E (1989) Ovarian hyperstimulation: an update review. Obstet Gynecol Surv 44,430-440.
17. Gómez R, Simón C, Remohí J and Pellicer A (2002) Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and its effect is prevented by receptor blockade. Endocrinology 143,4339-4348.
18. Hazzard T, Xu F and Stouffer R (2002) Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol Reprod 67,1305-1312
19. Isaza V, Garcia-Velasco JA, Aragones M, Remohi J, Simon C and Pellicer A (2002) Oocyte and embryo quality after coasting: the experience from oocyte donation. Hum Reprod 17,1777-1782.
20. Lee C, Tummon I, Martin J, Nisker J, Power S and Tekpetey F (1998) Does withholding gonadotropin administration prevent severe ovarian hyperstimulation syndrome? Hum Reprod 13,1157-1158.
21. McClure N, Healy D, Rogers P, Sullivan J, Beaton L, Haning R Jr, Connolly D and Robertson D (1994) Vascular endothelial cell growth factor as permeability agent in ovarian hyperstimulation syndrome. Lancet 344,235-236.
22. Meldrum D (2002) Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil Steril 78,1170-1171.
23. Rockwell L, Pillai S, Olson E and Koos R. (2002) Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67,1804-1810.
24. Sher G, Salem R, Feinman M, Dodge S, Zouves C and Knutzen V (1993) Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 81,1009-1011.
25. Simón C, Garcia-Velasco JA, Valbuena D, Peinado JA, Moreno C, Remohi J and Pellicer A (1998) Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril 70,234-239.
26. Tortoriello D, McGovern P, Colon J, Loughlin J and Santoro N (1998) Coasting does not affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril 69,454-460.
27. Verheul HM, Hoekman K, Luykx-de-Bakker S, Eekman CA, Folman CC, Broxterman HJ and Pinedo HM (1997) Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3,2187-2190.
28. Waldestrom U, Kahn J, Marsk L and Nilsson S (1999) High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by prolonged coasting of very hyperstimulated patients: a multicentre study. Hum Reprod 14,294-297.
29. Wang T, Horno S, Chang C, Wu H, Tsai Y, Wang H and Soong Y (2002) Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87,3300-3308.
30. Wheelan JG III and Vlahos NF (2000) The ovarian hyperstimulation syndrome. Fertil Steril 73,883-896.
31. Yan Z, Wich H, Bernart W, Breckwoldt M and Neulen J (1993) Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab 77,1723-1725.